Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 28-34

  Zhang, Si Ming ^a   Coultas, Kristen A ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Chemotherapy; Plumbagin; Sanguinarine; Schistosomiasis

Indexed keywords

ALBENDAZOLE; AMODIAQUINE; ANACARDIC ACID; APICIDIN; ARACHIDONIC ACID; ARTEMETHER; ATOVAQUONE; BERBERINE; CHELIDONINE; CHLOROQUINE; CLOSANTEL; CURCUMIN; DICLOFENAC; DIDEMETHOXYCURCUMIN; DIPYRIDAMOLE; DOXYCYCLINE HYCLATE; ETACRYNIC ACID; ETAZOLATE; HALOFANTRINE; HUMIC ACID; IBUPROFEN; LAPACHOL; LAWSONE; LEVAMISOLE; MACROLIDE; MEBENDAZOLE; MEFLOQUINE; PLUMBAGIN; SANGUINARINE; UNINDEXED DRUG;

ANIMAL CELL; ANTHELMINTIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; IN VITRO STUDY; INFECTION CONTROL; MICROBIAL MORPHOLOGY; NONHUMAN; PARASITE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WORLD HEALTH ORGANIZATION; WORM;

EID: 84872405303     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.12.001     Document Type: Article

References (55)

1. Abdul-Ghani R., Loutfy N., Sheta M., Hassan A. Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. Parasitol. Res. 2011, 108:1199-1205.
2. Abdulla M.H., Lim K.C., Sajid M., McKerrow J.H., Caffrey C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med. 2007, 4:e14.
3. Achan J., Talisuna A.O., Erhart A., Yeka A., Tibenderana J.K., Baliraine F.N., Rosenthal P.J., D'Alessandro U. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar. J. 2011, 10:144.
4. Ali A., Assimopoulou A.N., Papageorgiou V.P., Kolodziej H. Structure/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns. Planta Med. 2011, 77:2003-2012.
5. Allam G. Immunomodulatory effects of curcumin treatment on murine Schistosomiasis mansoni. Immunobiology 2009, 214:712-727.
6. Beech R.N., Skuce P., Bartley D.J., Martin R.J., Prichard R.K., Gilleard J.S. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 2011, 138:160-174.
7. Brown D., Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discov. Today 2003, 8:106-1077.
8. Caffrey C.R., Secor W.E. Schistosomiasis: from drug deployment to drug development. Curr. Opin. Infect. Dis. 2011, 24:410-417.
9. Cichewicz R.H., Lim K.V., McKerrow J.H., Nair M.G. Kwanzoquinones A-G and other constituents of Hemerocallis fulva 'Kwanzo' roots and their activity against the human pathogenic trematode Schistosoma mansoni. Tetrahedron 2002, 58:8597-8606.
10. Cioli D., Pica-Mattoccia L., Archer S. Drug resistance in schistosomes. Parasitol. Today 1993, 9:162-166.
11. Coultas K.A., Zhang S.-M. In vitro cercariae transformation: comparison of mechanical and nonmechanical methods and observation of morphological changes of detached cercariae tails. J. Parasitol. 2012, 10.1645/GE-30721.1.
12. Eissa M.M., El-Azzouni M.Z., Amer E.I., Baddour N.M. Miltefosine, a promising novel agent for Schistosomiasis mansoni. Int. J. Parasitol. 2011, 41:235-242.
13. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 1994, 51:83-88.
14. Geary T.G., Chibale K., Abegaz B., Andrae-Marobela K., Ubalijoro E. A new approach for anthelmintic discovery for human. Trends Parasitol. 2012, 28:176-181.
15. Hotez P.J., Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl. Trop. Dis. 2009, 3:e485.
16. Hwaka S., Hudson A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov. 2006, 5:941-955.
17. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 1999, 60:932-935.
18. Kayser O., Olbrich C., Croft S.L., Kiderlen A.F. Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs. Parasitol. Res. 2003, 2:S63-S70.
19. Keiser J., Manneck T., Vargas M. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. J. Antimicrob. Chemother. 2011, 66:1791-1797.
20. King C.H. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010, 113:95-104.
21. Lorsuwannarat N., Saowakon N., Ramasoota P., Wanichanon C., Sobhon P. The anthelmintic effect of plumbagin on Schistosoma mansoni. Exp. Parasitol. 2012, 10.1016/j.exppara.2012.10.003.
22. Luz P.P., Magalhães L.G., Pereira A.C., Cunha W.R., Rodrigues V., Andrade E., Silva M.L. Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity. Parasitol. Res. 2012, 110:593-598.
23. Magalhães L.G., Machado C.B., Morais E.R., Moreira E.B., Soares C.S., da Silva S.H., da Silva Filho A.A., Rodrigues V. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res. 2009, 104:1197-1201.
24. Magalhães L.G., Kapadia G.J., da Silva Tonuci L.R., Caixeta S.C., Parreira N.A., Rodrigues V., da Silva Filho A.A. In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol. Res. 2010, 106:395-401.
25. Magnussen P. Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10years' experiences. Acta Trop. 2003, 86:243-254.
26. Manneck T., Haggenmüller Y., Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 2010, 137:85-98.
27. Martin R.J., Robertson A.P. Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery. Adv. Exp. Med. Biol. 2010, 692:138-154.
28. McWilliam H.E., Driguez P., Piedrafita D., McManus D.P., Meeusen E.N. Novel immunomic technologies for schistosome vaccine development. Parasite Immunol. 2012, 34:276-284.
29. Melman S.D., Steinauer M.L., Cunningham C., Kubatko L.S., Mwangi I.N., Wynn N.B., Mutuku M.W., Karanja D.M., Colley D.G., Black C.L., Secor W.E., Mkoji G.M., Loker E.S. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl. Trop. Dis. 2009, 3:e504.
30. Miller L.H., Su X. Artemisinin: discovery from the Chinese herbal garden. Cell Host Microbe 2011, 6:855-858.
31. Müllner A., Helfer A., Kotlyar D., Oswald J., Efferth T. Chemistry and pharmacology of neglected helminthic diseases. Curr. Med. Chem. 2011, 18:767-789.
32. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25years. J. Nat. Prod. 2007, 70:461-477.
33. Oliveira A.B., Dolabela M.F., Braga F.C., Jácome R.L., Varotti F.P., Póvoa M.M. Plant-derived antimalarial agents: new leads and efficient phythomedicines. Part I. Alkaloids. An. Acad. Bras. Cienc. 2009, 81:715-740.
34. Padhye S., Dandawate P., Yusufi M., Ahmad A., Sarkar F.H. Perspective on medicine properties of plumbagin and its analogs. Med. Res. Rev. 2012, 32:1131-1158.
35. Pica F., Balestrieri E., Serafino A., Sorrentino R., Gaziano R., Moroni G., Moroni N., Palmieri G., Mattei M., Garaci E., Sinibaldi-Vallebona P. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs 2012, 23:32-42.
36. Renslo A.R., McKerrow J.U. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol. 2006, 2:701-710.
37. Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011, 6:93-108.
38. Ribeiro-dos-Santos G., Verjovski-Almeida S., Leite L.C. Schistosomiasis - a century searching for chemotherapeutic drugs. Parasitol. Res. 2006, 99:505-521.
39. Sanderson L., Bartlett A., Whitfield P.J. In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. J. Helminthol. 2002, 76:241-247.
40. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 2008, 14:407-412.
41. Secor W.E. The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr. Opin. HIV AIDS 2012, 7:254-259.
42. Selvi B.R., Pradhan S.K., Shandilya J., Das C., Sailaja B.S., Shankar G.N., Gadad S.S., Reddy A., Dasgupta D., Kundu T.K. Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem. Biol. 2009, 16:203-216.
43. Seubert J., Pohlke R., Loebich F. Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes. Experientia 1977, 33:1036-1037.
44. Sharma N., Shukla A.K., Das M., Dubey V.K. Evaluation of plumbagin and its derivative as potential modulators of redox thiol metabolism of Leishmania parasite. Parasitol. Res. 2012, 110:341-348.
45. Sissoko M.S., Dabo A., Traore H., Diallo M., Traore B., Konate D., Niare B., Diakite M., Kamate B., Traore A., Bathily B., Tapily A., Toure O.B., Cauwenbergh S., Jansen H.F., Doumbo O.K. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 2009, e6732.
46. Srinivasan L., Mathew N., Muthuswamy K. In vitro antfilarial activity of glutathione S-transferase inhibitors. Parasitol. Res. 2009, 105:1179-1183.
47. Sun M., Lou W., Chun J.Y., Cho D.S., Nadiminty N., Evans C.P., Chen J., Yue J., Zhou Q., Gao A.C. Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer 2010, 1:283-292.
48. van den Enden E. Pharmacotherapy of helminth infection. Expert Opin Pharmacother. 2009, 10:435-451.
49. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003, 86:125-139.
50. Webster J.P., Koukounari A., Lamberton P.H., Stothard J.R., Fenwick A. Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 2009, 136:1789-1799.
51. WHO, 2012. Accelerating work to overcome the global impact of neglected tropical disease: a roadmap for implementation. http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.
52. Xiao S.H., Mei J.Y., Jiao P.Y. Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum. Parasitol. Res. 2011, 108:399-406.
53. Xiao S.H., Xue J., Zhang H.B. Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro. Parasitol. Res. 2011, 110:1239-1248.
54. Yao J.Y., Shen J.Y., Li X.L., Xu Y., Hao G.J., Pan X.Y., Wang G.X. Effect of sanguinarine from the leaves of Macleaya cordata against Ichthyophthirius multifiliis in grass carp (Ctenopharyngodon idella). Parasitol. Res. 2010, 107:1035-1042.
55. Zhang S.-M., Coultas K.A. Identification and characterization of five transcription factors that are associated with evolutionarily conserved immune signaling pathways in the schistosome-transmitting snail Biomphalaria glabrata. Mol. Immunol. 2011, 48:1868-1881.